Robert Uhl

Robert Joined Westwicke in 2011 as a member of the life science team where he works with both public and private companies in the specialty pharmaceutical and biotechnology sector. His expertise spans the spectrum of investor relations activities including strategic buy-side and sell-side relationship building, corporate messaging and positioning, and investor perception audits.